305 related articles for article (PubMed ID: 36172197)
21. Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.
Viegas C; Patrício AB; Prata J; Fonseca L; Macedo AS; Duarte SOD; Fonte P
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765331
[TBL] [Abstract][Full Text] [Related]
22. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
24. Self-therapeutic metal-based nanoparticles for treating inflammatory diseases.
Han R; Xiao Y; Bai Q; Choi CHJ
Acta Pharm Sin B; 2023 May; 13(5):1847-1865. PubMed ID: 37250153
[TBL] [Abstract][Full Text] [Related]
25. Biologically Responsive Nanosystems Targeting Cardiovascular Diseases.
Song Z; Song K; Xiao Y; Guo H; Zhu Y; Wang X
Curr Drug Deliv; 2021; 18(7):892-913. PubMed ID: 33504306
[TBL] [Abstract][Full Text] [Related]
26. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
Ozeki T; Tagami T
Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
[TBL] [Abstract][Full Text] [Related]
27. Recent advancements in the cardiovascular drug carriers.
Singh B; Garg T; Goyal AK; Rath G
Artif Cells Nanomed Biotechnol; 2016; 44(1):216-25. PubMed ID: 25046615
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy.
Marcazzan S; Varoni EM; Blanco E; Lodi G; Ferrari M
Oral Oncol; 2018 Jan; 76():1-7. PubMed ID: 29290280
[TBL] [Abstract][Full Text] [Related]
29. The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine.
Sharifi S; Caracciolo G; Pozzi D; Digiacomo L; Swann J; Daldrup-Link HE; Mahmoudi M
Adv Drug Deliv Rev; 2021 Jul; 174():337-347. PubMed ID: 33957181
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in targeted nanomedicine as promising antitumor therapeutics.
Hejmady S; Pradhan R; Alexander A; Agrawal M; Singhvi G; Gorain B; Tiwari S; Kesharwani P; Dubey SK
Drug Discov Today; 2020 Dec; 25(12):2227-2244. PubMed ID: 33011342
[TBL] [Abstract][Full Text] [Related]
31. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Properties of PDMS Nanoparticles: A Promising New Drug Delivery Vehicle against Inflammatory Conditions.
Ajitha AA; Kumar SS; Viswanathan G; Baby S; Biju PG
Comb Chem High Throughput Screen; 2022; 25(10):1672-1681. PubMed ID: 33568028
[TBL] [Abstract][Full Text] [Related]
33. The importance of nanoparticle shape in cancer drug delivery.
Truong NP; Whittaker MR; Mak CW; Davis TP
Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
[TBL] [Abstract][Full Text] [Related]
34. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
35. Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics.
Wang Y; Wang C; Li K; Song X; Yan X; Yu L; He Z
J Control Release; 2021 Feb; 330():618-640. PubMed ID: 33417985
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
37. Challenges in development of nanoparticle-based therapeutics.
Desai N
AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
[TBL] [Abstract][Full Text] [Related]
38. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
Khan AU; Khan M; Cho MH; Khan MM
Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
40. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
